Published in BMC Med on August 26, 2014
Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology. World J Gastroenterol (2015) 0.78
Comparative accuracy of CT, dual-echo MRI and MR spectroscopy for preoperative liver fat quantification in living related liver donors. Indian J Radiol Imaging (2016) 0.78
A new noninvasive technique for estimating hepatic triglyceride: will liver biopsy become redundant in diagnosing non-alcoholic fatty liver disease? BMC Med (2014) 0.76
A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem (1957) 173.99
Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser (2000) 70.59
Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol (1999) 14.07
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther (2011) 7.91
Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology (2005) 7.03
Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology (2009) 3.31
Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther (2012) 3.25
Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging (2011) 2.75
Liver fat content and T2*: simultaneous measurement by using breath-hold multiecho MR imaging at 3.0 T--feasibility. Radiology (2008) 2.25
Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. Mod Pathol (1998) 2.13
Nonalcoholic fatty liver disease. Ann Epidemiol (2007) 2.09
Comparison of the Bligh and Dyer and Folch methods for total lipid determination in a broad range of marine tissue. Lipids (2001) 2.00
Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology (2013) 1.77
MRI: the new reference standard in quantifying hepatic steatosis? Gut (2011) 1.61
Quantification of hepatic steatosis with 3-T MR imaging: validation in ob/ob mice. Radiology (2010) 1.53
Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy. Radiology (2009) 1.40
Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology (2013) 1.30
Assessment of donor liver steatosis: pathologist or automated software? Hum Pathol (2004) 1.17
Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C. J Clin Pathol (2001) 1.15
Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging--correlation with histopathologic findings. Radiology (2006) 1.12
Feasibility of quantitative intrahepatic lipid imaging applied to the magnetic resonance dual gradient echo sequence. Magn Reson Med Sci (2003) 0.98
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. Antivir Ther (2012) 0.86
Liver methylene fraction by dual- and triple-echo gradient-echo imaging at 3.0T: Correlation with proton MR spectroscopy and estimation of robustness after SPIO administration. J Magn Reson Imaging (2011) 0.85
In vivo 3T spectroscopic quantification of liver fat content in nonalcoholic fatty liver disease: Correlation with biochemical method and morphometry. J Hepatol (2010) 0.85
Noninvasive liver steatosis quantification using MRI techniques combined with blood markers. Eur J Gastroenterol Hepatol (2010) 0.83
Detection of a fatty liver after binge drinking: correlation of MR-spectroscopy, DECT, biochemistry and histology in a rat model. Acad Radiol (2011) 0.80
Accurate fat fraction quantification by multiecho gradient-recalled-echo magnetic resonance at 1.5T in rats with nonalcoholic fatty liver disease. Eur J Radiol (2011) 0.79
Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med (2012) 7.18
Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol (2009) 2.53
The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status. Eur J Cancer (2008) 2.08
Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: a Nationwide Multicenter Study in Spain. Am J Gastroenterol (2007) 1.92
Role of magnetic resonance cholangiopancreatography in patients with suspected choledocholithiasis. Mayo Clin Proc (2002) 1.84
5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer. Gastroenterology (2010) 1.71
Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants. Am J Gastroenterol (2007) 1.67
Risk of cancer in cases of suspected lynch syndrome without germline mutation. Gastroenterology (2013) 1.55
Oncogenicity of the developmental transcription factor Sox9. Cancer Res (2012) 1.55
Oxygen therapy for acute myocardial infarction. Cochrane Database Syst Rev (2010) 1.54
Basaloid squamous cell carcinoma of the head and neck: a clinicopathological and follow-up study of 40 cases and review of the literature. Head Neck Pathol (2008) 1.48
MR quantification of hepatic iron concentration. Radiology (2003) 1.48
Risk of advanced proximal neoplasms according to distal colorectal findings: comparison of sigmoidoscopy-based strategies. J Natl Cancer Inst (2013) 1.47
Effectiveness of adalimumab in perianal fistulas in crohn's disease patients naive to anti-TNF therapy. J Clin Gastroenterol (2015) 1.45
[Clinicopathological characteristics and survival outcome of esophageal cancer. Results from a series of 200 patients]. Med Clin (Barc) (2009) 1.39
[Carcinoid tumor of the intrahepatic biliary tract]. Cir Esp (2006) 1.39
[The shuttle run test is not valid for the detection of asthma in school physical education programs]. Arch Bronconeumol (2006) 1.39
Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis. Hepatology (2012) 1.38
Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterol (2008) 1.37
Clinical patterns and outcomes of ischaemic colitis: results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study). Scand J Gastroenterol (2010) 1.33
Assessment of the increase in variability when combining volumetric data from different scanners. Hum Brain Mapp (2009) 1.30
Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study. Clin Gastroenterol Hepatol (2012) 1.28
Malignant colorectal polyps. World J Gastroenterol (2010) 1.27
A high degree of LINE-1 hypomethylation is a unique feature of early-onset colorectal cancer. PLoS One (2012) 1.24
Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study. Am J Gastroenterol (2009) 1.23
Clinical performance of original and revised Bethesda guidelines for the identification of MSH2/MLH1 gene carriers in patients with newly diagnosed colorectal cancer: proposal of a new and simpler set of recommendations. Am J Gastroenterol (2006) 1.22
Mouse models of pancreatic cancer. World J Gastroenterol (2012) 1.20
Modifiable endoscopic factors that influence the adenoma detection rate in colorectal cancer screening colonoscopies. Gastrointest Endosc (2012) 1.15
Takotsubo cardiomyopathy: assessment with cardiac MRI. AJR Am J Roentgenol (2010) 1.13
Decreased corticospinal tract fractional anisotropy predicts long-term motor outcome after stroke. Stroke (2013) 1.12
Epigenetic regulation of autophagy by the methyltransferase G9a. Mol Cell Biol (2013) 1.10
'Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures. Helicobacter (2003) 1.06
The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe. Helicobacter (2004) 1.05
Changes in white adipose tissue metabolism induced by resveratrol in rats. Nutr Metab (Lond) (2011) 1.03
Littoral-cell angioma of the spleen: a case report. World J Gastroenterol (2007) 1.03
MSH6 and MUTYH deficiency is a frequent event in early-onset colorectal cancer. Clin Cancer Res (2010) 1.01
Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individuals. Gastrointest Endosc (2013) 1.00
Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer. Drug Metab Rev (2012) 1.00
Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib. Hepatology (2013) 0.98
Cytomegalovirus hepatitis and myopericarditis. World J Gastroenterol (2007) 0.98
Adjuvant and neoadjuvant treatment in pancreatic cancer. World J Gastroenterol (2012) 0.96
Effects of resveratrol on obesity-related inflammation markers in adipose tissue of genetically obese rats. Nutrition (2013) 0.96
Patterns of local recurrence in rectal cancer after a multidisciplinary approach. World J Gastroenterol (2011) 0.96
Anastrozole-induced hepatotoxicity. Eur J Gastroenterol Hepatol (2006) 0.95
Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice. Am J Gastroenterol (2008) 0.94
Impact of polyphenols and polyphenol-rich dietary sources on gut microbiota composition. J Agric Food Chem (2013) 0.93
Fecal immunochemical test accuracy in familial risk colorectal cancer screening. Int J Cancer (2013) 0.92
Thermogenesis is involved in the body-fat lowering effects of resveratrol in rats. Food Chem (2013) 0.92
Usefulness of combining intermittent hypoxia and physical exercise in the treatment of obesity. J Physiol Biochem (2011) 0.91
Inflammatory mediators of hepatic steatosis. Mediators Inflamm (2010) 0.91
A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12. BMC Genomics (2013) 0.91
Effect of resveratrol on alcohol-induced mortality and liver lesions in mice. BMC Gastroenterol (2006) 0.90
Diagnostic performance of fecal immunochemical test and sigmoidoscopy for advanced right-sided colorectal neoplasms. Dig Dis Sci (2014) 0.89
Genetic susceptibility variants associated with colorectal cancer prognosis. Carcinogenesis (2013) 0.89
Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet. Nutrition (2012) 0.88
c-Met in pancreatic cancer stem cells: therapeutic implications. World J Gastroenterol (2012) 0.88
[III Spanish Consensus Conference on Helicobacter pylori infection]. Gastroenterol Hepatol (2013) 0.88
Prevalence and characteristics of MUTYH-associated polyposis in patients with multiple adenomatous and serrated polyps. Clin Cancer Res (2014) 0.88
Relevance of GSTM1, GSTT1, and GSTP1 gene polymorphisms to gastric cancer susceptibility and phenotype. Mutagenesis (2012) 0.87
Delipidating effect of resveratrol metabolites in 3T3-L1 adipocytes. Mol Nutr Food Res (2012) 0.87
MicroRNAs in biliary diseases. World J Gastroenterol (2012) 0.87
Colorectal cancer prognosis twenty years later. World J Gastroenterol (2010) 0.87
Resveratrol metabolites modify adipokine expression and secretion in 3T3-L1 pre-adipocytes and mature adipocytes. PLoS One (2013) 0.87
Fatty acid synthase methylation levels in adipose tissue: effects of an obesogenic diet and phenol compounds. Genes Nutr (2014) 0.87
Effects of resveratrol on changes induced by high-fat feeding on clock genes in rats. Br J Nutr (2013) 0.86
Oxygen use in acute myocardial infarction: an online survey of health professionals' practice and beliefs. Emerg Med J (2010) 0.86
BMP2/BMP4 colorectal cancer susceptibility loci in northern and southern European populations. Carcinogenesis (2012) 0.86
Clinical subtypes and molecular characteristics of serrated polyposis syndrome. Clin Gastroenterol Hepatol (2013) 0.86
The trans-10,cis-12 isomer of conjugated linoleic acid reduces hepatic triacylglycerol content without affecting lipogenic enzymes in hamsters. Br J Nutr (2004) 0.85
Guide and Position of the International Society of Nutrigenetics/Nutrigenomics on Personalised Nutrition: Part 1 - Fields of Precision Nutrition. J Nutrigenet Nutrigenomics (2016) 0.85
High-throughput sequencing of microRNAs in peripheral blood mononuclear cells: identification of potential weight loss biomarkers. PLoS One (2013) 0.85
trans-10,cis-12 Conjugated linoleic acid inhibits lipoprotein lipase but increases the activity of lipogenic enzymes in adipose tissue from hamsters fed an atherogenic diet. Br J Nutr (2006) 0.85
Comparison between magnetic resonance cholangiopancreatography and ERCP for evaluation of the pancreatic duct. Am J Gastroenterol (2002) 0.84
Oxygen therapy for acute myocardial infarction. Cochrane Database Syst Rev (2013) 0.84
Alcohol consumption on pancreatic diseases. World J Gastroenterol (2013) 0.84
Resveratrol does not increase body fat loss induced by energy restriction. J Physiol Biochem (2014) 0.83
Reporting quality of survival analyses in medical journals still needs improvement. A minimal requirements proposal. J Clin Epidemiol (2013) 0.83
Molecular markers in pancreatic cancer diagnosis. Clin Chim Acta (2013) 0.83
[Pancreatic metastases due to renal carcinoma. Our cases and a literature review]. Cir Esp (2012) 0.83
Prognosis and follow-up of 135 patients with ischemic colitis over a five-year period. World J Gastroenterol (2013) 0.83
Biochemical determination of lipid content in hepatic steatosis by the Soxtec method. World J Gastroenterol (2010) 0.82
Olive oil feeding up-regulates uncoupling protein genes in rat brown adipose tissue and skeletal muscle. Am J Clin Nutr (2002) 0.82
MicroRNAs and cholestatic liver diseases. Curr Opin Gastroenterol (2014) 0.82
Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: the RECLICU Study. J Crohns Colitis (2010) 0.82
Evidence for classification of c.1852_1853AA>GC in MLH1 as a neutral variant for Lynch syndrome. BMC Med Genet (2011) 0.82